Publication | Closed Access

FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients

Tumor BiologyMedicinePathologyCancer GenomicsCisplatin-based Chemotherapy ResistanceCancer BiologyPoor PrognosisFoxm1 ExpressionCancer TreatmentCancer GeneticsOncologyCell BiologyLung CancerCancer Research